The first randomized trial to compare photon- and proton-based radiation therapy for breast cancer finds that patients report equally strong health-related quality of life with either treatment.
MIDDLETON, Wis., Sept. 28, 2025 /PRNewswire/ -- Leo Cancer Care is using ASTRO 2025 to launch Grace™, the company's upright photon therapy system. Grace is named after American computer scientist and ...
The single-arm trial followed 63 adults with lower-grade gliomas treated with proton therapy. After five years, 79.1% of patients remained free from tumor progression. Overall survival reached 85.6%.
Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up We investigated the SEER-Medicare linked database, identifying patients with ...
In the article that accompanies this editorial, Howard et al 1 provide a state of the union summary regarding the status of proton therapy in the United States. Proton therapy is a rapidly growing ...
Results from the health-related quality of life (HRQOL) analysis of the University of Pennsylvania and RTOG Foundation RadComp study indicated that both photon and proton radiation treatment options ...
Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...
Intensity-modulated proton therapy (IMPT) matched intensity-modulated radiation therapy (IMRT) for progression-free survival in a phase III trial of oropharyngeal cancer. Patients receiving proton ...
New research suggests the targeted radiation treatment may reduce long-term side effects while maintaining strong cancer ...
In a phase 3 trial of patients with stage III or IV oropharyngeal cancer, intensity-modulated proton therapy (IMPT) resulted in noninferior progression-free survival and better overall survival than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results